-+ 0.00%
-+ 0.00%
-+ 0.00%

Astorg-backed Solabia plans sale of microbiology diagnostics unit to Oxoid Remel Microbiology

PUBT·10/20/2026 06:26:55
Listen to the news
Astorg-backed Solabia plans sale of microbiology diagnostics unit to Oxoid Remel Microbiology
  • Astorg-backed Solabia plans to sell its microbiology diagnostics division to fellow portfolio company Oxoid Remel Microbiology.
  • The divestment would focus Solabia on cosmetics, nutrition and life sciences; Astorg acquired Oxoid Remel Microbiology in August 2026.
  • Solabia became the world’s leading independent cosmetic active ingredients supplier with its June 2026 acquisition of Mibelle Biochemistry; other acquisitions included PolymerExpert.
  • Muriel Koch will succeed Jean-Baptiste Dellon as Solabia’s president and CEO, effective October 29, 2026.
  • The proposed sale remains subject to consultation processes, definitive agreements and regulatory approvals.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Astorg Partners SAS published the original content used to generate this news brief on October 20, 2026, and is solely responsible for the information contained therein.